01 SANOFI SpA (3)
02 Sanofi-Aventis (Suisse) SA (4)
03 ACCORD HEALTHCARE LIMITED (3)
04 AUROBINDO PHARMA ITALIA Srl (5)
05 Actavis Group PTC ehf (3)
06 Actavis Switzerland AG (2)
07 FRESENIUS KABI ONCOLOGY PLC (3)
08 Fresenius Kabi (Schweiz) AG (2)
09 HOSPIRA ITALIA Srl (3)
10 Hospira UK Limited (3)
11 MYLAN SpA (2)
12 SANDOZ GMBH (3)
13 SANDOZ SpA (4)
14 SUN PHARMACEUTICAL IND.EU.B.V. (3)
15 Sandoz Pharmaceuticals AG (2)
16 Stragen Pharma SA (2)
17 Sun Pharmaceutical - Netherlands (3)
18 TEVA ITALIA Srl (3)
19 Teva Pharma AG (2)
20 The Fresenius Kabi Oncology Plc (3)
01 Oxaliplatin (58)
01 Italy (32)
02 Norway (12)
03 Switzerland (14)
01 Concentrate to the infusion fluid, resolution (12)
02 Infusion (12)
03 Oxaliplatino 100Mg 20Ml 1 Units Parenteral Use (11)
04 Oxaliplatino 150Mg 30Ml 1 Units Parenteral Use (2)
05 Oxaliplatino 200Mg 40Ml 1 Units Parenteral Use (8)
06 Oxaliplatino 50Mg 10Ml 1 Units Parenteral Use (11)
07 Blank (2)